cariporide has been researched along with Hyperglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, L; Peng, Q; Wang, S; Zhang, J | 1 |
| Kaloyianni, M; Koliakos, G; Paletas, K; Tsapas, A; Zolota, Z | 1 |
2 other study(ies) available for cariporide and Hyperglycemia
| Article | Year |
|---|---|
Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
Topics: Animals; Calcium; Calpain; Cells, Cultured; Chelating Agents; Cysteine Proteinase Inhibitors; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelium, Vascular; Glucose; Guanidines; HSP90 Heat-Shock Proteins; Humans; Hyperglycemia; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Small Interfering; Sodium-Hydrogen Exchangers; Sulfones; Time Factors; Vasodilation; Vasodilator Agents | 2008 |
Cariporide counteracts atherosclerosis-related functions in monocytes from obese and normal individuals.
Topics: Adult; Atherosclerosis; CD36 Antigens; Cell Adhesion; Cell Movement; Female; Guanidines; Humans; Hyperglycemia; Male; Matched-Pair Analysis; Monocytes; Obesity; Sodium-Hydrogen Exchangers; Sulfones | 2005 |